Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share

128,928
Pharmaprojects

Last Loaded on Web: Wednesday, May 01, 2013

Last Update To Bluesheet: May 1, 2007

Bluesheet Contents     PDF version

File Description Print Counterparts DIALINDEX/OneSearch Categories Basic Index Rank
Subject Coverage Dialog File Data Contact Additional Indexes Map
Sources Geographic Coverage Terms and Conditions Limit Predefined Format Options
Tips Special Features Sample Record Sort Rates


File Description [top]

Pharmaprojects reports on the progress of new pharmaceutical products, both new chemical entities and biotechnological entities, at all stages of development from early pharmacological studies either to final launch in all major markets or to discontinuation for scientific or commercial reasons.

File 128 is the public file; File 928 is the subscriber file, available to those who subscribe to the print Pharmaprojects.



Tips [top]

USE FILE 128

to track pharmaceutical products in all stages of development.

USE /CO OR CO=

to find companies of interest.

USE /NA OR NA=

to search Drug names.

USE /TG

to search for Target Data.



Subject Coverage [top]

Pharmaprojects primarily addresses the information needs of the pharmaceutical industry and closely related fields, but is also of interest to those involved in the evaluation of pharmaceutical company performance. Each entry contains the product name, synonyms, originating company and development status, licensees and development status, stage of development in up to 40 countries, rigorously classified therapeutic activity, drug protein target, chemical name (conforming to CAS index name format where possible), CAS® Registry Number, molecular formula, pharmacology and patent/priority data, and descriptive text with key literature references.



Sources [top]

Pharmaprojects is compiled from both published and unpublished sources. A considerable amount of information is obtained directly from the companies involved in product development. In addition, Pharmaprojects staff attend international meetings to obtain information directly from research scientists. They also scan conference proceedings and the scientific and medical literature to track new products. Pharmaprojects also has a rigorous programme of contacting the companies in the publication and regularly scanning their websites to ensure that Pharmaprojects is a completely up-to-date source of international pharmaceutical product development information.



Print Counterparts [top]

  • Pharmaprojects


Dialog File Data [top]

Dates Covered: Products in active development
File Size: More than 35,000 records as of July 2012
Update Frequency: Weekly


Geographic Coverage [top]

  • International


Geographic Restrictions [top]

  • None


Special Features [top]

  • ERA Available
  • KWIC and HILIGHT Available
  • DIALOG Alert Available
  • Image Output Available
  • Abstracts Available
  • MAP Available


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
CASREGNO CAS(R) Registry Numbers-Chemical and Medical Files
DRUGDEV Drug Development Pipeline
DRUGDIR Drug Directories
PHARM Pharmacology
PHARMR Pharmacology + RINGDOC-Files
PHARMREG Pharmaceutical Regulation


Contact [top]

Pharmaprojects is provided by Informa UK Ltd. Questions concerning file content should be directed to:

Informa UK Ltd.
Pharmaprojects Helpdesk
69-77 Paul Street
London, EC2A 4LQ
United Kingdom
Telephone: +44 (0) 20 7017 6868 (Helpdesk)
Fax: +44 (0) 20 7017 6905
E-Mail: pharmaprojects.help@informa.com


Terms and Conditions [top]

For Dialog's Electronic Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply.

Information in this database is copyrighted by Informa UK Ltd. All rights reserved. Informa UK Ltd. makes no warranties, express or implied, with respect to the accuracy, quality, validity, or completeness of this database or the information therein.

Informa UK Ltd. wishes to protect against infringement of its copyright and the conditions of use of its databases while allowing fair use of material supplied to its customers. Informa UK Ltd. requires payment of a fair and reasonable fee for reproduction and redistribution of information in its database(s) EXCEPT those activities listed below and those covered by the ERA(sm) service.

ALLOWED WITHOUT PERMISSION OR CHARGE

1. Online users of Informa UK Ltd. online databases may download data from those databases onto a personal computer (PC) or into their personal electronic mailbox and integrate that information into a computer file held on that PC.

2. Members of staff of the customer organisation at the customer location where the Informa UK Ltd. data is downloaded may examine the computer file holding that data, provided that this is done at the PC on which it is held.

3. Information downloaded onto a receiving PC may be moved to another PC located at the customer location provided the Informa UK Ltd. data is held on only one (1) PC and is accessible only at that PC.

4. Permission is granted to make one (1) electronic copy of the downloaded Informa UK Ltd. data for back-up security purposes to be used only if the first copy becomes unusable.

5. Online users may make occasional printed hardcopies of the downloaded Informa UK Ltd. data and this hardcopy may be examined by members of the customer organisation working at the customer location where the downloading took place. The hardcopy may be kept for reference in a central location such as a library at the customer location where downloading took place. Additional copying of this hardcopy is a breach of the copyright of Informa UK Ltd.

6.The downloaded Informa UK ltd. data is restricted to employees of the customer and may not be exploited whether by way of sale, licence or to otherwise to any third party.

7. Informa UK Ltd. data may only be held in electronic form for a maximum period of 60 days from the date it is first downloaded and must then be deleted.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    PHARMAPROJECTS 
    (c)2012 Informa UK Ltd. All rights reserved. 
     
    0000077393 
  /DN,DN=,/NA,NA=  Drug Name:     venlafaxine hydrochloride 
  /ST,ST=  Global Status:  Launched 
  /SY,SY=  Synonyms:      OS-300 
                   OS300 
                   OSE-300 
                   OSE300 
  /CO,CO=,/LO,LO=  Originator:    Osmotica [Launched] 
  /CO,CO=,/LI,LI=  Licensee:      UCB [Launched] 
  LU=  Latest Upd:    Updated On  Latest Change 
                   20120625    Product details confirmed 
     
    ACTIVITY DATA 
  /TC  Therapy:       Description – Status 
                   Antidepressant -- [Launched] 
    (. . .) 
  /RO  Rte of Admin:  Description 
                   Oral; Oral, swallowed 
  /PH  Pharmacology:  Description 
                   5 Hydroxytryptamine uptake inhibitor 
                   Adrenergic transmitter uptake inhibitor 
                   Serotonin and norepinephrine reuptake inhibitor 
  /IN  Indication:    Description – Status 
                   Depression, major depressive disorder – Launched 
                   Social anxiety disorder – Launched 
     
  /TG  TARGET DATA: 6530: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 
    6532: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 
  /TF  Target Families: 
    6530: Transporter > Porters (uni-, sym- and anti-) 
    6532: Transporter > Porters (uni-, sym- and anti-) 
     
    CHEMICAL DATA 
  /OM,OM=  Origin:        Description 
                   Chemical, synthetic 
  NC=  New Entity:    No 
  RN=  CAS Reg. No:   93413-69-5 
                   99300-78-4 
  /CN,CN=  Chemical Name: Cyclohexanol, 
                   1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, 
                   hydrochloride 
     
    COUNTRY DATA 
  /ST,ST=  Country       Status/Licensing Opportunity 
                  USA      Launched 2008/Unknown 
  /UP,UP=  MAJOR EVENTS 
     
                Event Date Event—Details 
                20080520 First Registrations--The US; Major depressive and 
    Social anxiety disorder 
                20081009 First Launches--The US; Major depressive and Social 
    anxiety disorder 
                20120627 New Chemical Structure—New 
  /TX  TEXT: 
    Osmotica has developed an extended-release formulation of venlafaxine 
    hydrochloride, using its Osmodex controlled-release technology, for the 
    treatment of major depressive disorder and social anxiety disorder (. . .) 
    Marketing 
    Approvals 
     ________________ 
    USA; it is approved via the 505(b)(2) pathway (NDA Approval Letter, 20 May 2008, 
    Filings 
     ________________ 
    EU; an MAA was filed (Company Web Page, Osmotica, 25 Jun 2012, 
    Licensing 
    Agreements 
     ________________ 
    USA; it is marketed in the US by Upstate Pharma (UCB) (Press 
    release, Osmotica, 9 Oct 2008, http://www.osmotica.com/index.php?flag=what_is_new). 
  PD=  Published:    20120704 
     


BASIC INDEX [top]

SEARCH
SUFFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
None -- All Basic Index Fields Word S ABBOTT
/CO CO Company Name1,2 Word S OSMOTICA/CO
/DN DN Drug Name1 Word
& Phrase
S VENLAFAXINE(W)HYDROCLORIDE/DN
S VENALFAXINE HYDROCHLORIDE/DN
/IN IN Indication Word S SOCIAL(W)ANXIETY/IN
/LI LI Licensee and Status1 Word S UCB/LI
/LO LO Originator and Status1 Word S OSMOTICA/LO
/NA NA Drug Name1,3 Word S VENAFAXINE(W)HYDROCHLORIDE/NA
/OM OM Origin of Material Word S CHEMICAL(w)SYNTHETIC?/OM
/PH PH Pharmacology Word
& Phrase
S 5(W)HYDROXYTRYPTAMINE/PH
S 5 HYDROXYTRYPTAMINE?/PH
/PK PK Pharmacokinetic Data Word S HUMAN(F)CMAX/PK
/RO RO Route of Administration Text Word S ORAL/RO
/ST ST Status1 Word S LAUNCHED/ST
/SY SY Synonyms1,4 Word
& Phrase
S OS(W)300/SY
S OS-300/SY
/TC TC Therapeutic Class Text Word
& Phrase
S ANTIDEPRESSANT/TC
S FORMULATION MODIFIED?/TC
/TF TF Target Family Word S ENZYME(W)KINASE/TF
/TG TG Target Data Word S 2322/TG
/TX TX Text Word S SOCIAL(W)ANXIETY/TX
/UP UP Major Events Word S MAJOR(W)DEPRESSIVE/UP

1 Searchable in the Basic Index and in the Additional Indexes.

2 Includes Originator and Licensee.

3 Includes Chemical Name, Laboratory Code, and Brand Name.

4 Includes Laboratory Code and Brand Name.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
AC= AC Patent Application Country Phrase S AC=GB
AD= AD Patent Application Date Phrase S AD=20110327
AY= AY Priority Application Date1,2 Phrase S AY=2011
None AZ DIALOG Accession Number
CO= CO Company Name1,2 Phrase S CO=OSMOTICA
DN= DN Drug Name1 Phrase S DN=VENALFAXINE?
LI= LI Licensee1 Phrase S LI=UCB
LO= LO Originator1 Phrase S LO=OSMOTICA
LU= LU Latest Update1 Phrase S LU=20120625
MF= MF Molecular Formula Phrase S MF=C22H22N2O4
MW= MW Molecular Weight Numeric S MW=35.45
NA= NA Drug Name1,3 Phrase S NA=VENALFAXINE HYDRO?
NC= NC New Chemical Entity Phrase S NC=YES
PC= PC Patent Country Phrase S PC=GB
PH= PH Pharmacology Phrase S PH=5 HYDROXYTRYPTAMINE?
PN= PN Patent Number Phrase S PN=EP 02731178.6
PY= PY Revision Year Phrase S PY=2012
RN= RN CAS(R) Registry Number Phrase S RN=50-28-2
ST= ST Status1 Phrase S ST=LAUNCHED
SY= SY Synonyms1,4 Phrase S SY=OS-300
TG= TG Target Data1 Phrase S TG=2322
UD= None Update Phrase S UD=9999
UP= UP Major Events Phrase S UP=20080520


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/ACTIVE Drugs in Development S PHASE(W)III/ACTIVE
/CEASED Discontinued Drugs S ANTIASTHMA/CEASED
/LAUNCHED Fully Developed Drugs S SULINDAC/LAUNCHED
/YYYY Publication Year S TC=D5A/2012


SORT [top]

SORTABLE FIELDS EXAMPLES
CO, DN, LO, NA, PY SORT S1/ALL/LO
PRINT S5/5/1-24/NA


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. RANK CO S3


MAP [top]

MAP FIELDS EXAMPLES
DN, NA, RN, SY MAP NA TEMP S2
MAP SYRN TEMP S1


USER-DEFINED FORMAT OPTIONS [top]

The full record price will be charged for any field displayed with codes. User-defined formats can be specified using the display codes indicated in the Search Options tables. TYPE S3/CO,NA/1-5


PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT
RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Full Record
3 Medium Full Record
4 -- Full Record with Tagged Fields
5 -- Full Record
6 Free DIALOG Accession Number, Drug Name
7 Long Full Record
8 Short DIALOG Accession Number, Drug Name
9 Full Full Record
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
DIALOG Accession Number TYPE 0000032850/5
DISPLAY 0000075276/CO,NA
PRINT 0000077792/9


Rates [top]

Rates For File: Pharmaprojects[128]
Cost per DialUnit:               $105.00
Cost per minute:                  $23.83
Rank Elements                      $0.00
ALERT (default)                   $95.00
ALERT (Monthly)                  $162.00
ALERT (Biweekly/twice a month) * $108.00
ALERT (Weekly)                    $95.00
ALERT (Daily)                  *  $55.00
ALERT (Calendar weekly)        *  $95.00
ALERT (Intraday)               *  $55.00
* = custom scheduled Alerts only
ALERT Number of included prints        0

Format    Types   Prints
     1    $0.00    $0.00
     2   $60.00   $60.00
     3   $60.00   $60.00
     4   $60.00   $60.00
     5   $60.00   $60.00
     6    $0.00    $0.00
     7   $60.00   $60.00
     8    $0.00    $0.00
     9   $60.00   $60.00
    19   $60.00   $60.00
KWIC95   $60.00       NA
KWIC96   $60.00       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
---------------------------------

A charge of $20.00 applies to each CSS (Chemical Structure Search)
whether searching in one database or across multiple databases.  The
standard output charges for each database apply to any documents
retrieved.
Rates For File: Pharmaprojects - subscribers[928]
Cost per DialUnit:               $105.00
Cost per minute:                  $23.83
ALERT (default)                   $55.00
ALERT (Monthly)                   $84.00
ALERT (Biweekly/twice a month) *  $66.00
ALERT (Weekly)                    $55.00
ALERT (Daily)                  *  $55.00
ALERT (Calendar weekly)        *  $55.00
ALERT (Intraday)               *  $55.00
* = custom scheduled Alerts only
ALERT Number of included prints        0

Format    Types   Prints
     1    $0.00    $0.00
     2   $30.00   $30.00
     3   $30.00   $30.00
     4   $30.00   $30.00
     5   $30.00   $30.00
     6    $0.00    $0.00
     7   $30.00   $30.00
     8    $0.00    $0.00
     9   $30.00   $30.00
    19   $30.00   $30.00
KWIC95   $30.00       NA
KWIC96   $30.00       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
---------------------------------

A charge of $20.00 applies to each CSS (Chemical Structure Search)
whether searching in one database or across multiple databases.  The
standard output charges for each database apply to any documents
retrieved.
[top]



All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.